The emergence and spread of antibiotic resistance is one of the biggest challenges in public
health. There is an urgent need to discover novel agents against the occurrence of multidrug …

Despite the fact that we live in an era of advanced and innovative technologies for
elucidating underlying mechanisms of diseases and molecularly designing new drugs …

This review focuses on the development of nanoparticle systems for antimicrobial drug
delivery. Numerous antimicrobial drugs have been prescribed to kill or inhibit the growth of …

The core objective of nanoparticles is to control and manipulate biomacromolecular
constructs and supramolecular assemblies that are critical to living cells in order to improve …

Microbial resistance has increased in recent decades as a result of the extensive and
indiscriminate use of antibiotics. The World Health Organization listed antimicrobial …

Microbial resistance to current antibiotics therapies is a major cause of implant failure and
adverse clinical outcomes in orthopaedic surgery. Recent developments in advanced …

Bacterial infections are a significant cause of mortality and morbidity worldwide, despite
decades of use of numerous existing antibiotics and constant efforts by researchers to …

We report a new strategy for differential delivery of antimicrobials to bacterial infection sites
with a lipase-sensitive polymeric triple-layered nanogel (TLN) as the drug carrier. The TLN …

This review examines current technologies for increasing the bioavailability of antibiotics by
means of liposomes or nanoparticles. The main focus is on liposomes. These carriers were …

Used since ancient times especially for the local treatment of pulmonary diseases, lungs and
airways are a versatile target route for the administration of both local and systemic drugs …